Shakeel Sadia, Nesar Shagufta, Iffat Wajiha, Fatima Bilqees, Maqbool Tahmina, Jamshed Shazia
Faculty of Pharmaceutical Sciences, Dow University of Health Sciences, Karachi, Pakistan.
Faculty of Pharmacy, Hamdard University, Karachi, Pakistan.
Integr Pharm Res Pract. 2019 Jul 4;8:75-83. doi: 10.2147/IPRP.S196318. eCollection 2019.
The study was conducted with the aim to evaluate the prescribers' approach of interaction with medical representatives for drug promotion. An explanatory, cross-sectional design was used to evaluate prescribers' interactions with the medical sales representatives (MSRs) through an anonymous, self-filled questionnaire from June to December 2017. Data presented as means±SEM or as percentages and statistically analyzed by one way ANOVA, using significance level of 0.05. : A response rate of 82.8% was achieved. More than 70% agreed that knowledge obtained from MSRs is reliable and useful. A large proportion of respondents acknowledged that MSRs are a key link between pharmaceutical companies and health care professionals, and their interactions are beneficial as MSRs perform an important teaching function. More than 45% agreed that gifts are influential; however, physicians cannot be compromised with very expensive gifts. The majority of the respondents (76%) considered that promotional items are ethically appropriate; however, 66.21% thought that promotional items influence the practice of prescribing. More than half (52.18%) deemed a promotional material more reliable than a printed advertisement. More than 80% of the respondents opined that medication samples are considered appropriate; however, they should only be given to those patients who cannot financially afford them. Around 69% thought that company-sponsored meetings promote their own drugs under the disguise of CME programs. The present study emphasizes the importance of employing scientifically sound prescribing decision by prescribers in their day to day practice without being influenced by pharmaceutical company's promotional activities. There is a need for restricting unprincipled practices by the concerned regulatory authorities to evade preventable harm to the patient's well-being.
本研究旨在评估开处方者与医药代表互动以促进药品推广的方式。采用解释性横断面设计,通过一份匿名的自填问卷,于2017年6月至12月评估开处方者与医药销售代表(MSR)的互动情况。数据以均值±标准误或百分比形式呈现,并采用单因素方差分析进行统计分析,显著性水平为0.05。回复率达到82.8%。超过70%的人认为从医药代表那里获得的知识是可靠且有用的。很大一部分受访者承认医药代表是制药公司与医疗保健专业人员之间的关键纽带,并且他们的互动是有益的,因为医药代表发挥着重要的教学功能。超过45%的人认为礼品有影响力;然而,医生不会因非常昂贵的礼品而妥协。大多数受访者(76%)认为促销物品在道德上是合适的;然而,66.21%的人认为促销物品会影响处方行为。超过一半(52.18%)的人认为促销材料比印刷广告更可靠。超过80%的受访者认为药物样品是合适的;然而,它们应该只提供给那些经济上负担不起的患者。大约69%的人认为公司赞助的会议在继续医学教育(CME)项目的幌子下推广自家药品。本研究强调开处方者在日常实践中采用科学合理的处方决策的重要性,而不受制药公司促销活动的影响。相关监管机构有必要限制无原则的做法,以避免对患者福祉造成可预防的伤害。